Transaction · 0001193125-26-424350

Wilson James N

WILSON JAMES N, DIR, reported an open-market or private sale at CORCEPT THERAPEUTICS INC involving 6654.000000 shares for an estimated $761717.32. Reported holdings after the transaction were 1057889.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
CORTCORCEPT THERAPEUTICS INC
Trade date
Oct 15, 2026
Filing date
Oct 16, 2026
View on SEC Insider profile
Estimated value-$761kShares × reported price
Shares traded6.65k$114.48 per share
Holdings after1.05MIndirect · James N. Wilson and Pamela D. Wilson Trust
% of reported position traded0.63%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,064,543 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

CORT price since this filing

Daily closing prices, with the filing date and available return windows
CORT · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +0.6%1w ago +7.6%1d ago +5.5%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-424350
Common Stock
Transaction date
Oct 15, 2026
Filed Oct 16, 2026, 10:24 PM · 1d delay
Shares
6,654 sh
$114.48 per share
Estimated value
-$761k
Computed from shares × price
Holdings after
1,057,889 sh
Indirect · James N. Wilson and Pamela D. Wilson Trust

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Large Sale 10b5-1 Detected
Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction.

  2. F2

    Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.13 to $115.12 per share. Information on the exact number of shares sold at each…

  3. F3

    Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.16 to $116.10 per share. Information on the exact number of shares sold at each…

  4. F4

    Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.19 to $116.35 per share. Information on the exact number of shares sold at each…

  5. F5

    Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except…

Original filing · 0001193125-26-424350
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

CORT